MedTrace Logo

Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia

NCT06425757 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-10-01

No results posted yet for this study

Summary

Blood concentrations of Ciprofol were measured at different time points after single injection in patients with hypoproteinemia

Conditions

  • Hypoproteinemia
  • Pharmacokinetics
  • Ciprofol

Interventions

DRUG

ciprofol

Patients who intended to undergo elective surgery under general anesthesia were induced by a single intravenous injection of 0.3mg/kg and ciprofol, and the experimental drug was manually injected by CVC within 30s. 2ml of venous blood was collected before and after administration 0.5min, 1min, 2min, 3min, 5min, 8min, 15min 30min, 1h, 2h and 4h respectively. The concentration of cyclopofol in blood was measured

Sponsors & Collaborators

  • Xie Kangjie

    lead OTHER

Principal Investigators

  • XIE Kangjie, doctoral · Zhejiang Cancer Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-04
Primary Completion
2025-04-30
Completion
2025-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06425757 on ClinicalTrials.gov